Feasibility of Intensive Chemotherapy in Hereditary Spherocytosis.

ABSTRACT:

Background

This study presents a young man with hereditary spherocytosis (HS) who underwent intensive chemotherapy for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and achieved complete remission. This case challenges the idea of HS as a barrier to standard DLBCL treatment.

Discussion

By meticulously monitoring blood counts and providing timely transfusions, the team successfully mitigated potential complications associated with chemotherapy-induced stress on red blood cells.

Conclusions

This experience underscores the importance of a multidisciplinary approach and tailored treatment plans for patients with co-existing conditions, suggesting that HS should not automatically disqualify them from potentially curative therapies for aggressive lymphomas.

SUBMITTER: Valentina C 

PROVIDER: S-EPMC11932310 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature